liver disease
FDA Grants De Novo Authorization for Siemens Healthineers' Enhanced Liver Fibrosis Blood Test
The ELF Test provides prognostic information to assess the likelihood of a NASH patient progressing to cirrhosis and liver-related clinical events.
Owlstone Medical Entering Digestive Health Dx Space With Launch of Breath-Based Testing Service
Premium
The company is preparing to provide a clinical testing service that integrates hydrogen and methane biomarkers for digestive health conditions.
Digital Pathology Firm PathAI Raises $165M in Series C Financing
The company said it will use the new funding to accelerate product development and prioritize collaborations with pharmaceutical and diagnostic partners.
The French biotech company has indicated that it will likely create a wholly owned subsidiary that will house its diagnostics work.
Last month, the company raised seed funding from Bruker to work on diagnostic mass spectrometry-based tests that measure changes in protein glycosylation.
Aug 24, 2020
Fibronostics Raises $8M in Series A Round
Apr 29, 2020
DiscernDx Acquires Luminist Labs
Jun 11, 2019
Jan 3, 2019